As the world continues to evolve, it brings with it the increase of drug resistant microorganisms, the global spread of infectious disease and the threat of bioterrorism.
Ricerca has decades of experience in inflammation, allergy and immunology drug discovery and development. Our staff is highly skilled at providing primary- through tertiary-level in vivo and in vitro models that fulfill the needs of pharmaceutical and biotechnology companies at all stages of discovery.
Our inflammation/allergy/immunology therapeutic specialists include directors with extensive industry experience who have authored numerous peer-reviewed published articles. Our complete list of in vitro assays and in vivo validated models – using a broad panel of outcome measures – is conducted with expertise, prompt communication and a commitment to on-time reporting, enabling you to meet your drug development timelines.
ImmunoSignal™ is a cellular and ex vivo testing service offering cost-effective therapeutic and toxicity panels, as well as custom biomarker studies.
Biomarker – immunohistochemistry
Screening and profiling assays
OncoPanel™ – anti-cancer profiling and screening
Early safety screening – cellular toxicity